Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Protocolized GDMT Optimization Before Discharge in Heart Failure With Renal Dysfunction
jRCT1030260088Not yet recruiting
- Sponsor
- AstraZeneca
- Start
- Apr 2026
- Countries
- 1
01
Overview
Randomised trial in heart failure with reduced ejection fraction (HFrEF), heart failure with mid-range ejection fraction (HFmrEF) and chronic kidney disease (CKD) (2 arms), sponsored by AstraZeneca. Planned start Apr 2026; status: not yet recruiting.
02
Conditions
heart failure with reduced ejection fraction (HFrEF)heart failure with mid-range ejection fraction (HFmrEF)chronic kidney disease (CKD)
Beyond the preview
Go deeper on jRCT1030260088.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on jRCT1030260088.